Genelux Corp: Dr. Aladar Szalay Reports 4.18M Share Stake

TL;DR

**Insider owns 4.18M GNLX shares, showing strong conviction.**

AI Summary

Dr. Aladar Szalay, a key figure at Genelux Corp (GNLX), reported beneficial ownership of 4,185,305 shares of common stock as of December 31, 2023. This includes 4,180,305 shares with sole voting and dispositive power, and 5,000 shares with shared voting and dispositive power. This filing, an initial SC 13G, indicates his significant stake, which is important for investors as it shows a principal's strong alignment with the company's performance and future.

Why It Matters

This filing reveals a significant ownership stake by a key individual, Dr. Aladar Szalay, which can signal confidence in the company's future to investors.

Risk Assessment

Risk Level: low — This filing indicates a significant insider stake, generally viewed as a positive sign of confidence, thus lowering perceived risk.

Analyst Insight

Smart investors should view this significant insider ownership as a potential vote of confidence in Genelux Corp's future, warranting further research into the company's fundamentals and strategic direction.

Key Numbers

• 4,180,305 — Shares with Sole Voting Power (Number of shares Aladar Szalay can vote and dispose of independently.)
• 5,000 — Shares with Shared Voting Power (Number of shares Aladar Szalay shares voting and dispositive power over.)
• 4,185,305 — Total Beneficially Owned Shares (Combined total of shares Aladar Szalay beneficially owns.)
• December 31, 2023 — Date of Event (The date that triggered the requirement for this filing.)
• 36870H103 — CUSIP Number (Unique identification number for Genelux Corp's common stock.)

Key Players & Entities

• Aladar Szalay (person) — Reporting Person, beneficial owner of Genelux Corp shares
• GENELUX Corp (company) — Issuer of the common stock
• 03 Life Sciences (company) — Organization name associated with the subject company
• United States (person) — Citizenship of Aladar Szalay
• $0.001 (dollar_amount) — Par value per share of common stock

Forward-Looking Statements

• Aladar Szalay will maintain a significant ownership stake in Genelux Corp. (Aladar Szalay) — high confidence, target: Next 12 months
• The substantial insider ownership may positively influence investor confidence in Genelux Corp. (Genelux Corp) — medium confidence, target: Next 6 months

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• d764964dsc13g.htm (SC 13G) — 39KB
• 0001193125-24-022847.txt ( ) — 40KB

From the Filing

SC 13G 1 d764964dsc13g.htm SC 13G SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* GENELUX CORPORATION (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 36870H103 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 36870H103 SCHEDULE 13G Page 2 of 5 1 NAME OF REPORTING PERSON Aladar Szalay 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION United NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 4,180,305 (1) 6 SHARED VOTING POWER 5,000 (2) 7 SOLE DISPOSITIVE POWER 4,180,305 (1) 8 SHARED DISPOSITIVE POWER 5,000 (2) 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,185,305 (3) 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 15.7% (4) 12 TYPE OF REPORTING PERSON IN (1) Consists of (i) 1,371,545 shares of common stock held by The Szalay 2010 Retained Annuity Trust, (ii) 2,258,760 shares of common stock held by The Szalay 2009 Irrevocable Trust and (iii) 550,000 shares of common stock held by The Szalay 2010 Childrens Trust, for which the reporting person has sole voting and dispositive power. (2) Consists of 5,000 shares of common stock held by the reporting persons spouse, for which the reporting person has shared voting and dispositive power. (3) Consists of (i) 1,371,545 shares of common stock held by The Szalay 2010 Retained Annuity Trust, (ii) 2,258,760 shares of common stock held by The Szalay 2009 Irrevocable Trust and (iii) 550,000 shares of common stock held by The Szalay 2010 Childrens Trust, for which the reporting person has sole voting and dispositive power, and (iv) 5,000 shares of common stock held by the reporting persons spouse, for which the reporting person has shared voting and dispositive power. (4) This percentage is calculated based on 26,717,676 shares of common stock outstanding as of November 8, 2023, as reported in Genelux Corporations Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, filed with the Securities and Exchange Commission on November 14, 2023. CUSIP No. 36870H103 SCHEDULE 13G Page 3 of 5 Item1(a). Name of Issuer: Genelux Corporation Item1(b). Address of Issuers Principal Executive Offices: 2625 Townsgate Road, Suite 230 Westlake Village, California 91361 Item2(a). Names of Person Filing: Aladar Szalay Item2(b). Address of Principal Business Office, or, if none, Residence: 7704 North Fork Rd., Highland, CA 92346 Item2(c). Citizenship: United States Item2(d). Title of Class of Securities: Common Stock, par value $0.001 per share Item2(e). CUSIP No.: 36870H103 Item3. Not Applicable. Item4. O wnership. (a) Amount beneficially owned: See Row 9 of cover page. (b) Percent of class: See Row 11 of cover page. (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: See Row 5 of cover page for the Reporting Person. (ii) Shared power to vote or to direct the vote: See Row 6 of cover page for the Reporting Person. (iii) Sole power to dispose or to direct the disposition of: See Row 7 of cover page for the Reporting Person. (iv) Shared power to dispose or to direct the disposition of: See Row 8 of cover page for the Reporting Person. CUSIP No. 36870H103 SCHEDULE 13G Page 4 of 5 Item5. Not Applicable. Item6. Not Applicable. Item7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. Not Applicable. Item8. Identification and Classification of Members of the Group. Not Applicable. Item9. Notice of Dissolution of Group. Not Applicable. Item10. Certifications. Not applicable. CUSIP No. 36870H103 SCHEDULE 13G Page 5 of 5 SIGNATURE After reasonable inquiry and to the best of the undersigneds knowledge and beli

View Full Filing

View this SC 13G filing on SEC EDGAR